DRD2 expression based on 18 F-fallypride PET/MR predicts the dopamine agonist resistance of prolactinomas: a pilot study.
Hao TangYijun ChengXiaohui LouHong YaoJing XieWeiting GuXinyun HuangYanting LiuShaojian LinYuting DaiLi XueXiaozhu LinZhe Bao WuPublished in: Endocrine (2023)
F-fallypride PET/MR may be a promising technique for predicting DA response in patients with prolactinoma.